ITRM20060367A1 - Muteine del hngf usi terapeutici e composizioni farmaceutiche - Google Patents

Muteine del hngf usi terapeutici e composizioni farmaceutiche

Info

Publication number
ITRM20060367A1
ITRM20060367A1 ITRM20060367A ITRM20060367A1 IT RM20060367 A1 ITRM20060367 A1 IT RM20060367A1 IT RM20060367 A ITRM20060367 A IT RM20060367A IT RM20060367 A1 ITRM20060367 A1 IT RM20060367A1
Authority
IT
Italy
Prior art keywords
hngf
pharmaceutical compositions
therapeutic uses
mutein therapeutic
mutein
Prior art date
Application number
Other languages
English (en)
Inventor
Simona Capsoni
Antonino Cattaneo
Sonia Covaceuszach
Original Assignee
Lay Line Genomics Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lay Line Genomics Spa filed Critical Lay Line Genomics Spa
Priority to ITRM20060367 priority Critical patent/ITRM20060367A1/it
Priority to PCT/EP2007/057215 priority patent/WO2008006893A1/en
Publication of ITRM20060367A1 publication Critical patent/ITRM20060367A1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/48—Nerve growth factor [NGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ITRM20060367 2006-07-13 2006-07-13 Muteine del hngf usi terapeutici e composizioni farmaceutiche ITRM20060367A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ITRM20060367 ITRM20060367A1 (it) 2006-07-13 2006-07-13 Muteine del hngf usi terapeutici e composizioni farmaceutiche
PCT/EP2007/057215 WO2008006893A1 (en) 2006-07-13 2007-07-12 Muteins of hngf, therapeutic uses and pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM20060367 ITRM20060367A1 (it) 2006-07-13 2006-07-13 Muteine del hngf usi terapeutici e composizioni farmaceutiche

Publications (1)

Publication Number Publication Date
ITRM20060367A1 true ITRM20060367A1 (it) 2008-01-14

Family

ID=38508826

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM20060367 ITRM20060367A1 (it) 2006-07-13 2006-07-13 Muteine del hngf usi terapeutici e composizioni farmaceutiche

Country Status (2)

Country Link
IT (1) ITRM20060367A1 (it)
WO (1) WO2008006893A1 (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITUA20161364A1 (it) 2016-03-04 2017-09-04 Antonino Cattaneo Inibitore di tnf alpha astrocitario per l’uso nel trattamento di malattie neurologiche.
CN109071678B (zh) * 2016-03-18 2022-05-20 舒泰神（北京）生物制药股份有限公司 神经生长因子融合蛋白、制备方法及其用途
AR114110A1 (es) 2018-02-28 2020-07-22 Lilly Co Eli Anticuerpo anti-trka
WO2019207106A1 (en) 2018-04-27 2019-10-31 Chiesi Farmaceutici Spa Production of nerve growth factor (ngf) and of muteins thereof
JP2022502359A (ja) * 2018-09-17 2022-01-11 キエージ・フアルマチエウテイチ・エツセ・ピ・ア 皮膚科障害の処置のための薬剤
AU2020347812B2 (en) * 2019-09-17 2026-05-28 Chiesi Farmaceutici S.P.A. Agent for use in treatment or prevention of ophthalmic disorders
EP4188945A4 (en) * 2020-07-27 2024-10-02 Human Cell Co. NGF VARIANTS, PRODUCTION, COMPOSITIONS AND THERAPEUTIC USES
EP4039269A1 (en) * 2021-02-05 2022-08-10 Dompe' Farmaceutici S.P.A. Ngf isoform for use in the treatment of ocular pathologies
US20240165203A1 (en) 2021-03-25 2024-05-23 Chiesi Farmaceutici S.P.A. Combined treatment of brain injury
CN120500725A (zh) * 2022-12-28 2025-08-15 舒泰神（北京）生物制药股份有限公司 一种筛选和/或鉴定ngf中的可突变位点的方法及其筛选和/或鉴定ngf突变体的方法
US20260166124A1 (en) * 2024-12-17 2026-06-18 Dompe` farmaceutici S.P.A. Intranasal administration of ngf for the prevention or treatment of retinopathies and optic nerve disorders
EP4763217A1 (en) * 2024-12-17 2026-06-24 Dompé farmaceutici SpA Intranasal administration of ngf for the prevention or treatment of retinopathies and optic nerve disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365373B2 (en) * 1997-04-25 2002-04-02 Genentech, Inc. Nucleic acids encoding NGF variants
JP2001527402A (ja) * 1997-04-25 2001-12-25 ジェネンテック，インコーポレーテッド Ｎｇｆ変異体
WO2005040335A2 (en) * 2003-10-23 2005-05-06 Monika Holmberg A novel mutated nerve growth factor beta gene, proteins encoded thereby, and products and methods related thereto

Also Published As

Publication number Publication date
WO2008006893A1 (en) 2008-01-17

Similar Documents

Publication Publication Date Title
BRPI0813955A2 (pt) composições terapêuticas e o uso das mesmas
EP1962961A4 (en) DEMIKÖRPER: DIMERIZATION-ACTIVATED THERAPEUTIC AGENT
BRPI0923283A2 (pt) conjugados terapêuticos de peptídeo e usos dos mesmos
DK2185164T3 (da) Sammensætning og terapeutisk antitumorvaccine
NO20075628L (no) Farmasøytiske formuleringer
DK1959991T3 (da) Terapeutisk vaccine
CY2014030I1 (el) Θεραπευτικες συνθεσεις που περιλαμβανουν ingenol-3-angelate
BRPI0820381A2 (pt) Formulações farmacêuticas
EP2017280A4 (en) METALOCENCIPLEX AND POLYMERIZATION CATALYST COMPOSITION THEREIN
DK2073795T3 (da) Misbrugssikret lægemiddelformulation
BRPI0511900A (pt) composições farmacêuticas
BRPI1009324A2 (pt) compostos e/ou farmaceuticamente aceitáveis dos mesmos, composição farmacêutica e respectivos usos
ATE542815T1 (de) Kokristalle und pharmazeutische zusammensetzungen damit
BRPI0813000A2 (pt) Composições terapêuticas e uso das mesmas
BRPI0807544A2 (pt) Sólido farmacêutico e dose de vacina
DK1884242T3 (da) Farmaceutisk sammensætning omfattende lurasidon
CR10619A (es) Mimeticuerpos de peptido-1 similar a glucagon de humano, composiciones, metodos y usos
ATE493119T1 (de) Pharmazeutische zusammensetzung
DK2035369T3 (da) Terapeutiske
BRPI0921947A2 (pt) formulações de proteína terapêutica
EP2185112A4 (en) Stabilized therapeutic compositions and formulations
BRPI0907228A2 (pt) Compostos de tienopiridazina, suas preparações, composições farmacêuticas e usos
ATE530546T1 (de) Kokristalle und pharmazeutische zusammensetzungen damit
EP2341047A4 (en) CYCLOHEXANDERIVATE AND PHARMACEUTICAL USE THEREOF
DE602008005137D1 (de) Chinolonverbindung und pharmazeutische zusammensetzung